Krystyna Wyka Selected Research

Krystyna Wyka Research Topics

Disease

23	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2022 - 01/2003
6	Insulin Resistance 01/2022 - 04/2003
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2011
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2020 - 06/2009
3	Disease Progression 01/2014 - 07/2009
2	Febrile Neutropenia 12/2023 - 12/2022
2	Infections 12/2022 - 01/2021
2	Hypersensitivity (Allergy) 04/2019 - 06/2009
2	Ketosis 12/2018 - 01/2004
2	Inflammation (Inflammations) 10/2016 - 07/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015 - 01/2007
1	Bacteremia 12/2023
1	Lymphoma (Lymphomas) 12/2023
1	Neutropenia 12/2022
1	Fever (Fevers) 12/2022
1	Neoplasms (Cancer) 12/2022
1	Mason-Type Diabetes 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2022
1	Obesity 01/2022
1	Glucose Intolerance 01/2022
1	Tuberous Sclerosis (Bourneville's Disease) 06/2021
1	Brain Injuries (Brain Injury) 06/2021
1	IgA Deficiency 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Stomatitis 10/2020
1	Birth Weight (Birth Weights) 06/2020
1	Body Weight (Weight, Body) 06/2020
1	Bronchopulmonary Dysplasia 08/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Pathologic Processes 12/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2016
1	Lung Neoplasms (Lung Cancer) 10/2016
1	Reinfection 03/2016
1	Thyroiditis 03/2016
1	Cataract (Cataracts) 01/2015
1	Diabetes Mellitus 01/2015
1	Hyperamylasemia 01/2015
1	Hyperbilirubinemia 01/2015
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2014

Drug/Important Bio-Agent (IBA)

9	AntibodiesIBA 01/2022 - 01/2003
8	AutoantibodiesIBA 01/2022 - 01/2003
7	Insulin (Novolin)FDA Link 12/2018 - 01/2003
6	C-PeptideIBA 12/2018 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2003
3	Immunoglobulin G (IgG)IBA 01/2021 - 03/2016
3	Immunoglobulin A (IgA)IBA 01/2021 - 03/2016
2	LigandsIBA 12/2022 - 01/2014
2	C-Reactive ProteinIBA 12/2022 - 10/2016
2	LipidsIBA 01/2022 - 09/2011
2	AntigensIBA 01/2022 - 01/2016
2	Immunoglobulin M (IgM)IBA 01/2021 - 04/2019
2	Interleukin-8 (Interleukin 8)IBA 06/2020 - 07/2014
2	CytokinesIBA 06/2020 - 01/2014
2	Asparaginase (Elspar)FDA Link 04/2019 - 06/2009
2	lipopolysaccharide-binding proteinIBA 01/2019 - 10/2016
2	Zinc Transporter 8IBA 12/2018 - 04/2014
2	Interleukin-6 (Interleukin 6)IBA 10/2016 - 07/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016 - 12/2012
2	Interleukin-18 (Interleukin 18)IBA 07/2014 - 01/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2011 - 01/2010
1	ProcalcitoninIBA 12/2022
1	ChemokinesIBA 12/2022
1	Trace Elements (Biometals)IBA 12/2022
1	NFI Transcription FactorsIBA 01/2022
1	trans-sodium crocetinate (crocetin)IBA 06/2021
1	Everolimus FDA Link 06/2021
1	TOR Serine-Threonine KinasesIBA 06/2021
1	IronIBA 06/2021
1	Calcium-Binding ProteinsIBA 06/2021
1	Immunoglobulin IsotypesIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Immunoglobulin D (IgD)IBA 01/2021
1	Fibroblast Growth Factor-23IBA 01/2021
1	SteroidsIBA 10/2020
1	alpha-2-HS-GlycoproteinIBA 06/2020
1	HLA-A Antigens (HLA-A)IBA 01/2020
1	EnzymesIBA 08/2019
1	Superoxide DismutaseIBA 08/2019
1	AntioxidantsIBA 08/2019
1	Immunoglobulin E (IgE)IBA 04/2019
1	MicroRNAs (MicroRNA)IBA 12/2018
1	Aligeron (AS 2)IBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2015
1	Hepatocyte Nuclear Factor 1-betaIBA 01/2015
1	InterleukinsIBA 07/2014
1	Tyrosine (L-Tyrosine)FDA Link 04/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2014
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 04/2014

Therapy/Procedure

3	Therapeutics 04/2019 - 06/2009
2	Radiotherapy 01/2019 - 10/2016
1	Stem Cell Transplantation 12/2023
1	BEAM regimen 12/2023
1	Drug Therapy (Chemotherapy) 10/2020
1	Remission Induction 10/2020
1	Cardiopulmonary Resuscitation (CPR) 06/2020
1	Glycemic Control 01/2017
1	Immunotherapy 12/2016